Tryptamines — psilocybin and DMT (N,N-Dimethyltryptamine)
We develop Tryptamines — such as psilocybin, DMT — and their analogs. The molecules produced by CB Therapeutics are pure, environmentally sustainable, chemically consistent, and never contaminated by insecticides or organic materials.
Biosynthesis has allowed us to unlock the sustainable and scalable production of a vast array of psychedelic molecules such as tryptamines.
If you are interested in tryptamines for legal clinical research, don’t hesitate to get in touch with us.
Psilocybin is a naturally-occurring psychedelic compound produced by more than 200 species of fungi worldwide. Research on psilocybin-assisted therapy includes its potential effects on anxiety, substance use disorder, treatment-resistant depression, and palliative care.
DMT is a tryptamine that occurs in many plants and animals and which is both a derivative and a structural analog of tryptamine. Research conducted on DMT-assisted therapy includes its potential effects on anxiety, substance use disorder, treatment-resistant depression, and palliative care.
We have developed a 16,000 sq. ft. fully-licensed commercial batch facility in southern California, including: